“‘In Living Color’ is this old comedy show, and Damon Wayans and David Alan Grier would play these characters who were so gay — like gayer than us! — and they would wear these tiny hats and puffy shirts and would review movies. And if they liked the movies, they would give it ‘two snaps.'”
— Comfy Cow co-founder Roy Koons-McGee, in a new Modern Louisville magazine story, explaining how the company developed one of the funny name for their ice cream: Ginger Two Snaps.
The investigation into William Brenner, 49, began after detectives with the Johnson County Sheriff’s Office received an abuse report June 7 from the state child welfare agency, involving a 6-year-old boy he was fostering, local news media are now reporting.
Brenner is accused of molesting the boy more than once in December 2014, and on into January 2015, according to documents filed in a Johnson County court. He faces four counts of felony child molesting and one count of felony dissemination of matter harmful to minors, according to the Indianapolis Star.
“The child stated while he was staying at the man’s residence, Brenner would touch the boy’s private areas on several occasions,” according to Fox 59. The Child Services report also says the boy revealed Brenner would make the boy touch him.
Detectives executed a search warrant on Brenner’s residence Wednesday. He told detectives during an interview that he made the child take nude photos of him, according to Fox.
Brenner is CFO at Kindred Greenwood, one of the company’s 95 transitional care and rehabilitation hospitals, according to his LinkedIn profile. Greenwood is 12 miles south of Indianapolis.
Louisville-based Kindred employs more than 2,200 workers in the city, and more than 100,000 nationwide. Here’s more about hospital and nursing giant’s history.
A news summary, focused on 10 big employers; updated 3:28 p.m.
HUMANA and Aetna now face an uphill battle persuading antitrust enforcers their planned $37 billion deal won’t harm competition, after high-level talks between the Justice Department and company officials yesterday ended without public word of their outcome. It isn’t clear when the agency will make a final call. Company officials have been preparing for a decision as soon as this month, according to The Wall Street Journal, which cited people familiar with the matter that the newspaper didn’t identify. But officials also disclosed June 24 that they’d extended the deadline for completing the deal until the end of the year.
Humana’s stock has been reeling since news of the negotiations suddenly emerged mid-day Thursday; shares have fallen 11% since the day before. Aetna’s stock has fallen, too, but by a far smaller 2%, reflecting what investment bank JP Morgan said yesterday is the Louisville company’s greater downside risk if the deal collapses (chart, top).
JP Morgan downgraded Humana’s stock to “neutral” from “overweight,” after the probability of a deal approval declined well below a 50/50 chance, analyst Gary Taylor said. If the deal were not to happen, Humana’s shares could fall to a range of as low as $115 to $125. At $115, Humana would have sunk to the lowest level since May 6, 2014, when shares closed at $109.79.
That grim outlook isn’t universal. Wedbush Securities analyst Sarah James told CNBC: “We’re 80 to 90% confident that the Aetna deal is going to go through,” she said (CNBC).
The developments at Humana-Aetna and two other companies also planning a merger — Anthem and Cigna, for $48 billion — “are the latest signs that federal officials are worried about consolidation among health insurers,” the WSJ says. The deals “would reshape the top of the industry, collapsing five large insurers into three giant firms, each with annual revenues of more than $100 billion” (Wall Street Journal).
BROWN FORMAN: The U.S. State Department spent $21,733 to distribute 840 fifths of Jack Daniel’s as “gratuities” Continue reading “Humana-Aetna now in limbo after DOJ talks; Haier planning super fridge; Amazon rockets to 4th most-valuable company, and check your wallet for a $540 million jackpot”
Boulevard 